Medizinische Universität Graz - Research portal
-
Ass.-Prof. Dr.rer.nat. Michael Dengler
- Division of Oncology
- EMail: michael.dengler(at)medunigraz.at
- Tel: +43/316/385/31428
- https://onkologie.medunigraz.at/en/research/identifying-new-cancer-drivers
- MEDonline-Visitenkarte
- Externe ID's
- ORCiD: 0000-0002-1693-1761
Statistik Austria, science classification
- Cell biology - (301114)
- Drug targeting - (301213)
- Medical molecular biology - (301306)
- Cancer research - (301904)
- Oncology - (302055)
Curr. Vitae
| 2022 -now | Tenure Track (Assistant) Professor for "Functional Precision Oncology", Division of Oncology, Medical University Graz, Austria |
| 2021 -2022 | University Assistant/Junior Group Leader, Division of Oncology, Medical University Graz, Austria |
| 2014 -2021 | Postdoc/Senior Postdoc, The Walter & Eliza Hall Institute of Medical Research, Melbourne, Australia. |
| 2010 -2014 | Doctoral studies, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; and University of Stuttgart |
| 2003 -2009 | Studies in Technical Biology, University of Stuttgart, Germany |
Awards
| 2022 | Start Funding - Medical University of Graz |
| 2018 | Science/Medicine Grant from CASS Foundation (Contributing to Australian Scholarship and Science) |
| 2016 | Walter & Eliza Hall Institute Postdoc Association International Travel Fellowship |
| 2014 | PhD with summa cum laude from University of Stuttgart, Germany |
| 2011 | American Society of Hematology (ASH) Abstract Achievement Award, 53rd ASH Annual Meeting, San Diego, USA |
Reviewer for scientific journals
| 2025 -2025 | SIGNAL TRANSDUCTION AND TARGETED THERAPY |
| 2019 -2024 | BLOOD |
| 2018 -2023 | CELL DEATH & DISEASE |
| 2022 -2022 | THE FEBS JOURNAL |
| 2017 -2017 | LEUKEMIA & LYMPHOMA |
| 2017 -2017 | MOLECULAR ONCOLOGY |
| 2016 -2016 | ONCOGENE |
Reviewer/Expert funding organizations
| 2024 -2024 | Bürgermeisterfond der Stadt Wien - Austria |